112 related articles for article (PubMed ID: 37516650)
21. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
[TBL] [Abstract][Full Text] [Related]
23. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
Blanchard P; Quero L; Pacault V; Schlageter MH; Baruch-Hennequin V; Hennequin C
BMC Cancer; 2012 Mar; 12():119. PubMed ID: 22448886
[TBL] [Abstract][Full Text] [Related]
25. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
26. Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Tsuchiya N; Kunisaki C; Sato S; Tanaka Y; Sato K; Watanabe J; Takeda K; Kosaka T; Akiyama H; Endo I
Langenbecks Arch Surg; 2022 Aug; 407(5):1911-1921. PubMed ID: 35230525
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.
Huang TC; Liang CW; Li YI; Guo JC; Lin CC; Chen YJ; Cheng AL; Hsu CH
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1803-1811. PubMed ID: 34432128
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
Yoneda M; Fujiwara H; Furutani A; Ikai A; Tada H; Shiozaki A; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Otsuji E
Anticancer Res; 2013 Jun; 33(6):2699-705. PubMed ID: 23749929
[TBL] [Abstract][Full Text] [Related]
30. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.
Xi M; Xu C; Liao Z; Hofstetter WL; Blum Murphy M; Maru DM; Bhutani MS; Lee JH; Weston B; Komaki R; Lin SH
Radiother Oncol; 2017 Aug; 124(2):318-324. PubMed ID: 28687396
[TBL] [Abstract][Full Text] [Related]
31. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer.
de Vos-Geelen J; Hoebers FJP; Geurts SME; Hoeben A; de Greef BTA; Voncken FEM; Bogers JHA; Braam PM; Muijs CKT; de Jong MA; Kasperts N; Rozema T; Jeene PM; Blom GJ; van Dieren JM; Hulshof MCCM; van Laarhoven HWM; Grabsch HI; Lemmens VEPP; Tjan-Heijnen VCG; Nieuwenhuijzen GAP
Acta Oncol; 2020 Aug; 59(8):895-903. PubMed ID: 32319845
[No Abstract] [Full Text] [Related]
32. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
[TBL] [Abstract][Full Text] [Related]
33. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
34. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum dynamics of HSP90a level in esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yan H; Li B; Fan T; Jiang S; Wang R; Sun M
Cancer Biomark; 2017; 19(2):185-192. PubMed ID: 28387662
[TBL] [Abstract][Full Text] [Related]
36. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.
Guo D; Liu J; Li Y; Li C; Liu Q; Ji S; Zhu S
J Inflamm Res; 2021; 14():6129-6141. PubMed ID: 34848991
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
